We also conducted a clinical sample test with GBM samples, and western blot analysis suggested that the expression of PDIA3 in nine GBM tissues was remarkably higher than that in normal tissues adjacent to cancer, further validating the high protein expression of PDIA3 in GBM. Here, PDIA3 is linked to cancer.